Factor VIIa-Tissue Factor: Functional Importance of Protein-Membrane Interactions

The first enzyme in the blood clotting cascade consists of two distinct protein subunits: a catalytic subunit (factor VIIa; FVIIa) and an essential regulatory subunit (tissue factor; TF). FVIIa is a soluble plasma protease, while TF is a cell-surface, integral-membrane protein. The recently reported X-ray crystal structure of the complex of FVIIa and the isolated extracellular domain of TF has provided important insights into the protein-protein interactions that bind these two subunits together (1). Equally important in the functioning of the TF-FVIIa complex, but much less well understood, are a series of protein-phospholipid interactions involving TF, FVIIa, and the natural substrates of this enzyme, as well as protein-protein interactions important in substrate recognition by TF-FVIIa. Here we review recent studies on the membrane organization and role of protein-phospholipid interactions in the function of TF-FVIIa, the enzyme that triggers blood clotting in hemostasis and thrombosis.

[1]  P. Neuenschwander,et al.  The Location of the Active Site of Blood Coagulation Factor VIIa above the Membrane Surface and Its Reorientation upon Association with Tissue Factor , 1996, The Journal of Biological Chemistry.

[2]  L. Petersen,et al.  Structurally and functionally distinct Ca2+ binding sites in the gamma-carboxyglutamic acid-containing domain of factor VIIa. , 1995, European journal of biochemistry.

[3]  M. Ultsch,et al.  Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. , 1994, Biochemistry.

[4]  D. Stuart,et al.  Crystal structure of the extracellular region of human tissue factor , 1994, Nature.

[5]  L. Petersen,et al.  Involvement of the hydrophobic stack residues 39–44 of factor VIIa in tissue factor interactions , 1994, FEBS letters.

[6]  P. Neuenschwander,et al.  Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. , 1994, The Journal of biological chemistry.

[7]  P. Neuenschwander,et al.  The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. , 1994, The Journal of biological chemistry.

[8]  P. Byfield,et al.  Synthesis and characterization of wild-type and variant gamma-carboxyglutamic acid-containing domains of factor VII. , 1993, Biochemistry.

[9]  P. Neuenschwander,et al.  Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. , 1993, The Journal of biological chemistry.

[10]  C. Esmon,et al.  Analysis of the functions of the first epidermal growth factor-like domain of factor X. , 1993, The Journal of biological chemistry.

[11]  Steven D. Carson,et al.  The role of tissue factor in the production of thrombin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  Y. Nemerson,et al.  Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. , 1993, Biochemistry.

[13]  J. Birktoft,et al.  Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction. , 1993, Biochemistry.

[14]  A. Janoff,et al.  The nature of antiphospholipid antibodies. , 1992, The Journal of rheumatology.

[15]  T. Miyata,et al.  Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. , 1992, The Journal of biological chemistry.

[16]  L. Petersen,et al.  Two different Ca2+ ion binding sites in factor VIIa and in des(1–38) factor VIIa , 1992, FEBS letters.

[17]  P. Neuenschwander,et al.  Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. , 1992, The Journal of biological chemistry.

[18]  W. Kisiel,et al.  The Role of Phospholipids and the Factor VII Gla-Domain in the Interaction of Factor VII with Tissue Factor , 1992, Thrombosis and Haemostasis.

[19]  A. Guha,et al.  Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. , 1992, Biochemistry.

[20]  A. Rehemtulla,et al.  Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. , 1992, The Journal of biological chemistry.

[21]  I W Caras,et al.  Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. , 1991, The Journal of biological chemistry.

[22]  P. Hass,et al.  Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. , 1991, The Journal of biological chemistry.

[23]  W. Kisiel,et al.  Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. , 1991, Biochemistry.

[24]  Y Komiyama,et al.  Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. , 1990, Biochemistry.

[25]  S. Rapaport,et al.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. , 1990, Thrombosis research.

[26]  B. Lentz,et al.  A new model to describe extrinsic protein binding to phospholipid membranes of varying composition: application to human coagulation proteins. , 1989, Biochemistry.

[27]  C. Esmon,et al.  The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. , 1987, The Journal of biological chemistry.

[28]  K. Kurachi,et al.  Characterization of a cDNA coding for human factor VII. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Comfurius,et al.  Changes in membrane phospholipid distribution during platelet activation. , 1983, Biochimica et biophysica acta.

[30]  W. Kisiel,et al.  Interaction of vitamin K dependent proteins with membranes. , 1978, Biochemistry.

[31]  L. McCoy,et al.  Phospholipid requirements of tissue thromboplastin in blood coagulation. , 1975, Thrombosis research.

[32]  Y. Nemerson Characteristics and lipid requirements of coagulant proteins extracted from lung and brain: the specifity of protein component of tissue factor. , 1969, The Journal of clinical investigation.

[33]  Surgenor Dm,et al.  Studies on the relationship between the colloidal state and clot-promoting activity of pure phosphatidylethanolamines. , 1959, The Journal of biological chemistry.

[34]  P. Neuenschwander,et al.  Substrate Recognition by Tissue Factor-Factor VIIa EVIDENCE FOR INTERACTION OF RESIDUES Lys AND Lys OF TISSUE FACTOR WITH THE 4-CARBOXYGLUTAMATE-RICH DOMAIN OF FACTOR X* , 1996 .

[35]  J. Morrissey Tissue Factor Modulation of Factor Vlla Activity:Use in Measuring Trace Levels of Factor Vlla in Plasma , 1995, Thrombosis and Haemostasis.

[36]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.

[37]  A. Rehemtulla,et al.  Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. , 1991, The Journal of biological chemistry.

[38]  T. Drake,et al.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. , 1989, The American journal of pathology.

[39]  Y. Nemerson,et al.  The phospholipid requirement of tissue factor in blood coagulation. , 1968, The Journal of clinical investigation.

[40]  G. Rouser,et al.  Phospholipid structure and thromboplastic activity. II. The fatty acid composition of the active phosphatidyl ethanolamines. , 1958, Biochimica et biophysica acta.